96 related articles for article (PubMed ID: 1909177)
1. Rational design of quinazoline-based irreversible inhibitors of human erythrocyte purine nucleoside phosphorylase.
Dempcy RO; Skibo EB
Biochemistry; 1991 Aug; 30(34):8480-7. PubMed ID: 1909177
[TBL] [Abstract][Full Text] [Related]
2. Active-site-directed reductive alkylation of xanthine oxidase by imidazo[4,5-g]quinazoline-4,9-diones functionalized with a leaving group.
Lee CH; Skibo EB
Biochemistry; 1987 Nov; 26(23):7355-62. PubMed ID: 3427077
[TBL] [Abstract][Full Text] [Related]
3. 9-[(Phosphonoalkyl)benzyl]guanines. Multisubstrate analogue inhibitors of human erythrocyte purine nucleoside phosphorylase.
Kelley JL; Linn JA; McLean EW; Tuttle JV
J Med Chem; 1993 Oct; 36(22):3455-63. PubMed ID: 8230137
[TBL] [Abstract][Full Text] [Related]
4. [[(Guaninylalkyl)phosphinico]methyl]phosphonic acids. Multisubstrate analogue inhibitors of human erythrocyte purine nucleoside phosphorylase.
Kelley JL; McLean EW; Crouch RC; Averett DR; Tuttle JV
J Med Chem; 1995 Mar; 38(6):1005-14. PubMed ID: 7699692
[TBL] [Abstract][Full Text] [Related]
5. Guanine, pyrazolo[3,4-d]pyrimidine, and triazolo[4,5-d]pyrimidine (8-azaguanine) phosphonate acyclic derivatives as inhibitors of purine nucleoside phosphorylase.
Beauchamp LM; Tuttle JV; Rodriguez ME; Sznaidman ML
J Med Chem; 1996 Feb; 39(4):949-56. PubMed ID: 8632418
[TBL] [Abstract][Full Text] [Related]
6. Purine nucleoside phosphorylase from human erythrocytes: a kinetic study of the fully separated isoenzymes.
Accorsi A; Piacentini MP; Piatti E; Fazi A
Biochem Int; 1991 May; 24(1):23-31. PubMed ID: 1768259
[TBL] [Abstract][Full Text] [Related]
7. Rabbit erythrocyte purine nucleoside phosphorylase. Differential-inactivation studies.
Savage B; Spencer N
Biochem J; 1979 Apr; 179(1):29-34. PubMed ID: 112995
[TBL] [Abstract][Full Text] [Related]
8. Calf spleen purine-nucleoside phosphorylase: crystal structure of the binary complex with a potent multisubstrate analogue inhibitor.
Luić M; Koellner G; Yokomatsu T; Shibuya S; Bzowska A
Acta Crystallogr D Biol Crystallogr; 2004 Aug; 60(Pt 8):1417-24. PubMed ID: 15272165
[TBL] [Abstract][Full Text] [Related]
9. One-third-the-sites transition-state inhibitors for purine nucleoside phosphorylase.
Miles RW; Tyler PC; Furneaux RH; Bagdassarian CK; Schramm VL
Biochemistry; 1998 Jun; 37(24):8615-21. PubMed ID: 9628722
[TBL] [Abstract][Full Text] [Related]
10. Partial purification and properties of purine nucleoside phosphorylase from rabbit erythrocytes.
Savage B; Spencer N
Biochem J; 1977 Dec; 167(3):703-10. PubMed ID: 414743
[TBL] [Abstract][Full Text] [Related]
11. [Regulatory mutants for the synthesis of a 2d purine nucleoside phosphorylase in Escherichia coli K-12. I. Synthesis inducers and the substrate specificity of purine nucleoside phosphorylase in pndR mutants].
Kocharian ShM; Kocharian AM; Melkumian MA; Bezirdzhian KhO; Akopian ZhI
Genetika; 1984 Sep; 20(9):1463-71. PubMed ID: 6437906
[TBL] [Abstract][Full Text] [Related]
12. The partial purification and characterization of purine nucleoside phosphorylase from mammalian mitochondria.
Haag R; Lewis RA
Mol Cell Biochem; 1994 Jun; 135(2):129-36. PubMed ID: 7838140
[TBL] [Abstract][Full Text] [Related]
13. Application of crystallographic and modeling methods in the design of purine nucleoside phosphorylase inhibitors.
Ealick SE; Babu YS; Bugg CE; Erion MD; Guida WC; Montgomery JA; Secrist JA
Proc Natl Acad Sci U S A; 1991 Dec; 88(24):11540-4. PubMed ID: 1763067
[TBL] [Abstract][Full Text] [Related]
14. 1-Azaribofuranoside analogues as designed inhibitors of purine nucleoside phosphorylase. Synthesis and biological evaluation.
Hansen SU; Bols M
Acta Chem Scand (Cph); 1998 Oct; 52(10):1214-22. PubMed ID: 9785443
[TBL] [Abstract][Full Text] [Related]
15. Rabbit erythrocyte purine nucleoside phosphorylase. Initial-velocity studies.
Savage B; Spencer N
Biochem J; 1979 Apr; 179(1):21-7. PubMed ID: 112994
[TBL] [Abstract][Full Text] [Related]
16. Purifications and properties of orotidine-phosphorolyzing enzyme and purine nucleoside phosphorylase from Erwinia carotovora AJ 2992.
Shirae H; Yokozeki K
Agric Biol Chem; 1991 Jul; 55(7):1849-57. PubMed ID: 1368721
[TBL] [Abstract][Full Text] [Related]
17. Structures for the potential drug target purine nucleoside phosphorylase from Schistosoma mansoni causal agent of schistosomiasis.
Pereira HD; Franco GR; Cleasby A; Garratt RC
J Mol Biol; 2005 Oct; 353(3):584-99. PubMed ID: 16182308
[TBL] [Abstract][Full Text] [Related]
18. Expression, purification, and characterization of recombinant purine nucleoside phosphorylase from Escherichia coli.
Lee J; Filosa S; Bonvin J; Guyon S; Aponte RA; Turnbull JL
Protein Expr Purif; 2001 Jul; 22(2):180-8. PubMed ID: 11437593
[TBL] [Abstract][Full Text] [Related]
19. Human erythrocytic purine nucleoside phosphorylase: reaction with sugar-modified nucleoside substrates.
Stoeckler JD; Cambor C; Parks RE
Biochemistry; 1980 Jan; 19(1):102-7. PubMed ID: 6766310
[TBL] [Abstract][Full Text] [Related]
20. Crystal structure of calf spleen purine nucleoside phosphorylase with two full trimers in the asymmetric unit: important implications for the mechanism of catalysis.
Bzowska A; Koellner G; Wielgus-Kutrowska B; Stroh A; Raszewski G; Holý A; Steiner T; Frank J
J Mol Biol; 2004 Sep; 342(3):1015-32. PubMed ID: 15342253
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
